Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.

L Moreno; M Casanova; JC Chisholm; P Berlanga; PB Chastagner; S Baruchel; L Amoroso; SG Melcón; NU Gerber; G Bisogno; F Fagioli; B Geoerger; G Vassal

doi:10.1016/j.ejca.2018.05.002

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.

L Moreno, M Casanova, JC Chisholm, P Berlanga, PB Chastagner, S Baruchel, L Amoroso, SG Melcón, NU Gerber, G Bisogno, F Fagioli, B Geoerger, G Vassal

Department of Paediatrics, Obstetrics and Gynaecology and Preventive Medicine and Public Health

Research output: Contribution to journal › Article › Research › peer-review

20 Citations (Scopus)

Original language	Undefined/Unknown
Journal	European journal of cancer (Oxford, England : 1990)
DOIs	https://doi.org/10.1016/j.ejca.2018.05.002
Publication status	Published - Jun 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2018.05.002

Cite this

Moreno, L., Casanova, M., Chisholm, JC., Berlanga, P., Chastagner, PB., Baruchel, S., Amoroso, L., Melcón, SG., Gerber, NU., Bisogno, G., Fagioli, F., Geoerger, B., & Vassal, G. (2018). Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2018.05.002

@article{5a3d781e1ecf4085b6e1acfd1ecfb72b,

title = "Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.",

author = "L Moreno and M Casanova and JC Chisholm and P Berlanga and PB Chastagner and S Baruchel and L Amoroso and SG Melc{\'o}n and NU Gerber and G Bisogno and F Fagioli and B Geoerger and G Vassal",

year = "2018",

month = jun,

doi = "10.1016/j.ejca.2018.05.002",

language = "Indefinido/desconocido",

}

Moreno, L, Casanova, M, Chisholm, JC, Berlanga, P, Chastagner, PB, Baruchel, S, Amoroso, L, Melcón, SG, Gerber, NU, Bisogno, G, Fagioli, F, Geoerger, B & Vassal, G 2018, 'Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.', European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2018.05.002

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer. / Moreno, L; Casanova, M; Chisholm, JC et al.

In: European journal of cancer (Oxford, England : 1990), 06.2018.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.

AU - Moreno, L

AU - Casanova, M

AU - Chisholm, JC

AU - Berlanga, P

AU - Chastagner, PB

AU - Baruchel, S

AU - Amoroso, L

AU - Melcón, SG

AU - Gerber, NU

AU - Bisogno, G

AU - Fagioli, F

AU - Geoerger, B

AU - Vassal, G

PY - 2018/6

Y1 - 2018/6

UR - http://europepmc.org/abstract/med/29936064

U2 - 10.1016/j.ejca.2018.05.002

DO - 10.1016/j.ejca.2018.05.002

M3 - Artículo

C2 - 29936064

ER -

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.

UN SDGs

Access to Document

Other files and links

Cite this